Rethinking protein aggregation and drug discovery in neurodegenerative diseases: Why we need to embrace complexity?

Hardy, 2002, The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics, Science, 297, 353, 10.1126/science.1072994 Liao, 2004, Proteomic characterization of postmortem amyloid plaques isolated by laser capture microdissection, J Biol Chem, 279, 37061, 10.1074/jbc.M403672200 Lutz, 2018, Deep profiling of the aggregated proteome in Alzheimer's disease: from pathology to disease mechanisms, Proteomes, 6, 10.3390/proteomes6040046 Leverenz, 2007, Proteomic identification of novel proteins in cortical lewy bodies, Brain Pathol, 17, 139, 10.1111/j.1750-3639.2007.00048.x Xia, 2008, Proteomic identification of novel proteins associated with Lewy bodies, Front Biosci, 13, 3850, 10.2741/2973 Stewart, 2017, Amyloid plaques beyond Abeta: a survey of the diverse modulators of amyloid aggregation, Biophys Rev, 9, 405, 10.1007/s12551-017-0271-9 Shahmoradian, 2019, Lewy pathology in Parkinson's disease consists of crowded organelles and lipid membranes, Nat Neurosci, 22, 1099, 10.1038/s41593-019-0423-2 Mahul-Mellier, 2020, The process of Lewy body formation, rather than simply alpha-synuclein fibrillization, is one of the major drivers of neurodegeneration, Proc Natl Acad Sci U S A, 117, 4971, 10.1073/pnas.1913904117 Trinkaus, 2021, In situ architecture of neuronal alpha-Synuclein inclusions, Nat Commun, 12, 2110, 10.1038/s41467-021-22108-0 Riguet, 2020, Disentangling the sequence, cellular and ultrastructural determinants of Huntingtin nuclear and cytoplasmic inclusion formation, bioRxiv Guerrero-Ferreira, 2018, Cryo-EM structure of alpha-synuclein fibrils, Elife, 7, 10.7554/eLife.36402 Ghosh, 2021, Molecular structure of a prevalent amyloid-beta fibril polymorph from Alzheimer's disease brain tissue, Proc Natl Acad Sci U S A, 118 Fitzpatrick, 2017, Cryo-EM structures of tau filaments from Alzheimer's disease, Nature, 547, 185, 10.1038/nature23002 Falcon, 2018, Tau filaments from multiple cases of sporadic and inherited Alzheimer's disease adopt a common fold, Acta Neuropathol, 136, 699, 10.1007/s00401-018-1914-z Scheres, 2020, Cryo-EM structures of tau filaments, Curr Opin Struct Biol, 64, 17, 10.1016/j.sbi.2020.05.011 Shi, 2021, Cryo-EM structures of tau filaments from Alzheimer’s disease with PET ligand APN-1607, Acta Neuropathol, 141, 697, 10.1007/s00401-021-02294-3 Arakhamia, 2020, Posttranslational modifications mediate the structural diversity of tauopathy strains, Cell, 180, 633, 10.1016/j.cell.2020.01.027 Kollmer, 2019, Cryo-EM structure and polymorphism of Abeta amyloid fibrils purified from Alzheimer's brain tissue, Nat Commun, 10, 4760, 10.1038/s41467-019-12683-8 Zhang, 2019, Heparin-induced tau filaments are polymorphic and differ from those in Alzheimer's and Pick's diseases, Elife, 8 Li, 2018, Cryo-EM of full-length alpha-synuclein reveals fibril polymorphs with a common structural kernel, Nat Commun, 9, 3609, 10.1038/s41467-018-05971-2 Guerrero-Ferreira, 2019, Two new polymorphic structures of human full-length alpha-synuclein fibrils solved by cryo-electron microscopy, Elife, 8, 10.7554/eLife.48907 Saborio, 2001, Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding, Nature, 411, 810, 10.1038/35081095 Wilham, 2010, Rapid end-point quantitation of prion seeding activity with sensitivity comparable to bioassays, PLoS Pathog, 6, 10.1371/journal.ppat.1001217 Peden, 2012, Sensitive and specific detection of sporadic Creutzfeldt-Jakob disease brain prion protein using real-time quaking-induced conversion, J Gen Virol, 93, 438, 10.1099/vir.0.033365-0 Metrick, 2020, A single ultrasensitive assay for detection and discrimination of tau aggregates of Alzheimer and Pick diseases, Acta Neuropathol Commun, 8, 22, 10.1186/s40478-020-0887-z Strohaker, 2019, Structural heterogeneity of alpha-synuclein fibrils amplified from patient brain extracts, Nat Commun, 10, 5535, 10.1038/s41467-019-13564-w Shahnawaz, 2020, Discriminating alpha-synuclein strains in Parkinson's disease and multiple system atrophy, Nature, 578, 273, 10.1038/s41586-020-1984-7 Lovestam, 2021, Seeded assembly in vitro does not replicate the structures of alpha-synuclein filaments from multiple system atrophy, FEBS Open Bio, 11, 999, 10.1002/2211-5463.13110 Fujiwara, 2002, alpha-Synuclein is phosphorylated in synucleinopathy lesions, Nat Cell Biol, 4, 160, 10.1038/ncb748 Hasegawa, 2008, Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis, Ann Neurol, 64, 60, 10.1002/ana.21425 Wesseling, 2020, Tau PTM profiles identify patient heterogeneity and stages of Alzheimer's disease, Cell, 183, 1699, 10.1016/j.cell.2020.10.029 Bhattacharjee, 2019, Mass spectrometric analysis of lewy body-enriched alpha-synuclein in Parkinson's disease, J Proteome Res, 18, 2109, 10.1021/acs.jproteome.8b00982 Sorrentino, 2020, The emerging role of alpha-synuclein truncation in aggregation and disease, J Biol Chem, 295, 10224, 10.1074/jbc.REV120.011743 Neumann, 2009, Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies, Acta Neuropathol, 117, 137, 10.1007/s00401-008-0477-9 Dujardin, 2020, Tau molecular diversity contributes to clinical heterogeneity in Alzheimer's disease, Nat Med, 26, 1256, 10.1038/s41591-020-0938-9 Li, 2011, Hyperphosphorylation as a defense mechanism to reduce TDP-43 aggregation, PLoS One, 6 Francois-Moutal, 2019, Structural insights into TDP-43 and effects of post-translational modifications, Front Mol Neurosci, 12, 301, 10.3389/fnmol.2019.00301 Burai, 2015, Elucidating the role of site-specific nitration of alpha-synuclein in the pathogenesis of Parkinson's disease via protein semisynthesis and mutagenesis, J Am Chem Soc, 137, 5041, 10.1021/ja5131726 Fauvet, 2013, One-pot total chemical synthesis of human alpha-synuclein, Chem Commun, 49, 9254, 10.1039/c3cc45353g Galesic, 2020, Investigating the effects of O-GlcNAc modifications in Parkinson's disease using semisynthetic alpha-synuclein, Methods Mol Biol, 2133, 313, 10.1007/978-1-0716-0434-2_15 Reimann, 2017, Tag-free semi-synthesis of the tau protein, Methods Mol Biol, 1523, 215, 10.1007/978-1-4939-6598-4_12 Haj-Yahya, 2020, Site-specific hyperphosphorylation inhibits, rather than promotes, tau fibrillization, seeding capacity, and its microtubule binding, Angew Chem Int Ed Engl, 59, 4059, 10.1002/anie.201913001 Haj-Yahya, 2018, Protein semisynthesis provides access to tau disease-associated post-translational modifications (PTMs) and paves the way to deciphering the tau PTM code in health and diseased states, J Am Chem Soc, 140, 6611, 10.1021/jacs.8b02668 Ellmer, 2019, Single posttranslational modifications in the central repeat domains of Tau4 impact its aggregation and tubulin binding, Angew Chem Int Ed Engl, 58, 1616, 10.1002/anie.201805238 Ansaloni, 2014, One-pot semisynthesis of exon 1 of the Huntingtin protein: new tools for elucidating the role of posttranslational modifications in the pathogenesis of Huntington's disease, Angew Chem Int Ed Engl, 53, 1928, 10.1002/anie.201307510 Schneider, 1999, Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments, Biochemistry, 38, 3549, 10.1021/bi981874p Zhao, 2020, Parkinson's disease-related phosphorylation at Tyr39 rearranges alpha-synuclein amyloid fibril structure revealed by cryo-EM, Proc Natl Acad Sci U S A, 117, 20305, 10.1073/pnas.1922741117 Wissner, 2013, Labeling proteins with fluorophore/thioamide Forster resonant energy transfer pairs by combining unnatural amino acid mutagenesis and native chemical ligation, J Am Chem Soc, 135, 6529, 10.1021/ja4005943 Warner, 2017, Monomeric huntingtin exon 1 has similar overall structural features for wild-type and pathological polyglutamine lengths, J Am Chem Soc, 139, 14456, 10.1021/jacs.7b06659 Robinson, 2018, Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated, Brain, 141, 2181, 10.1093/brain/awy146 Kovacs, 2019, Molecular pathology of neurodegenerative diseases: principles and practice, J Clin Pathol, 72, 725, 10.1136/jclinpath-2019-205952 St-Amour, 2018, Co-occurrence of mixed proteinopathies in late-stage Huntington's disease, Acta Neuropathol, 135, 249, 10.1007/s00401-017-1786-7 Charles, 2000, Alpha-synuclein immunoreactivity of huntingtin polyglutamine aggregates in striatum and cortex of Huntington's disease patients and transgenic mouse models, Neurosci Lett, 289, 29, 10.1016/S0304-3940(00)01247-7 Peng, 2018, Cellular milieu imparts distinct pathological alpha-synuclein strains in alpha-synucleinopathies, Nature, 557, 558, 10.1038/s41586-018-0104-4 Fares, 2021, Reverse engineering Lewy bodies: how far have we come and how far can we go?, Nat Rev Neurosci, 22, 111, 10.1038/s41583-020-00416-6 Kwon, 2020, Immunotherapies for aging-related neurodegenerative diseases-emerging perspectives and new targets, Neurotherapeutics, 17, 935, 10.1007/s13311-020-00853-2 Ross, 2004, Protein aggregation and neurodegenerative disease, Nat Med, 10, S10, 10.1038/nm1066 Forno, 1996, Neuropathology of Parkinson's disease, J Neuropathol Exp Neurol, 55, 259, 10.1097/00005072-199603000-00001 Schweighauser, 2020, Structures of alpha-synuclein filaments from multiple system atrophy, Nature, 585, 464, 10.1038/s41586-020-2317-6 Gremer, 2017, Fibril structure of amyloid-beta(1-42) by cryo-electron microscopy, Science, 358, 116, 10.1126/science.aao2825